Key Takeaways QDEL launches the QUICKVUE Influenza SARS Test, expanding its respiratory solutions portfolio.QuidelOrtho's test detects flu A, flu B and SARS-CoV-2 antigens from one sample with 10-minute results.The launch supports QDEL's Molecular Diagnostics and Point of Care units across U.S. clinical settings.Last week, QuidelOrtho Corporation (QDEL) announced the availability of QUICKVUE Influenza + SARS Test. The CLIA-waived, 510(k)–cleared rapid, easy-to-use immunoassay is the latest addition to the c ...